Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Clinical trial NCT01872923 · COMPLETED

Trial details

NCT number: NCT01872923
Sponsor: PCI Biotech AS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous or Sub-cutaneous Malignancies

Start date: 2012-01-01
Primary completion: 2012-10-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.